Anatoly Nemets
Anatoly Nemets publishes mostly in Oncology, Pathology and Forensic Medicine and Hematology, on topics such as Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research.
- World rank
- #2,132,364 of 7,710,434 ranked researchers
- Rank in Israel
- #14,166 of 38,292
- Works
- 34
- Citations
- 1.2k
- Citations per work
- 35.8
What does Anatoly Nemets research?
Anatoly Nemets's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2058.9%
- Medicine2058.9%
- Everything else1133.7%
- Life Sciences37.4%
- 1Oncology17% of their works
- 2Pathology and Forensic Medicine13% of their works
- 3Hematology13% of their works
- 4Genetics12% of their works
- 5Molecular Biology7% of their works
- 6Epidemiology5% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- CAR-T cell therapy research
- Protein Degradation and Inhibitors
- Immunodeficiency and Autoimmune Disorders
- Cutaneous lymphoproliferative disorders research
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Anatoly Nemets's research?
The keywords of their largest research topics: Rituximab, Lymphoma, Prognostic Factors, Classification, Diagnosis Criteria, International Myeloma Working Group, Molecular Profiling and Chronic Lymphocytic Leukemia.
- Pneumonia
- PROTACs
- Genetic Mutations
- BET Bromodomains
- CAR T Cells
- Chronic Lymphocytic Leukemia
- International Myeloma Working Group
- Classification
- Lymphoma
- Rituximab
- Prognostic Factors
- Diagnosis Criteria
- Molecular Profiling
- Genomic Aberrations
- Chimeric Antigen Receptor
- Cutaneous Lymphomas
- Mycosis Fungoides
- Pneumocystis
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Rituximab172 topics
- Lymphoma132 topics
- Prognostic Factors112 topics
- Classification91 topic
- Diagnosis Criteria91 topic
- International Myeloma Working Group91 topic
- Molecular Profiling91 topic
- Chronic Lymphocytic Leukemia81 topic
- Genomic Aberrations81 topic
- CAR T Cells41 topic
- Chimeric Antigen Receptor41 topic
- BET Bromodomains31 topic
- Cutaneous Lymphomas31 topic
- Genetic Mutations31 topic
- Mycosis Fungoides31 topic
- PROTACs31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
- Primary Immunodeficiency31 topic
Where does Anatoly Nemets work?
Anatoly Nemets's main affiliation in the publication record is Barzilai Medical Center, Israel.
How many publications and citations does Anatoly Nemets have?
OpenAlex counts 34 works and 1,216 citations for Anatoly Nemets, an h-index of 10, ranking #2,132,364 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anatoly Nemets. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.